132 related articles for article (PubMed ID: 18842429)
21. Immunophenotypic and cytomorphologic subclassification of T-cell lymphoma in the boxer breed.
Lurie DM; Milner RJ; Suter SE; Vernau W
Vet Immunol Immunopathol; 2008 Sep; 125(1-2):102-10. PubMed ID: 18579219
[TBL] [Abstract][Full Text] [Related]
22. Augmented chemokine levels and chemokine receptor expression on immune cells during pulmonary tuberculosis.
Pokkali S; Das SD
Hum Immunol; 2009 Feb; 70(2):110-5. PubMed ID: 19100801
[TBL] [Abstract][Full Text] [Related]
23. Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma.
Jones D; O'Hara C; Kraus MD; Perez-Atayde AR; Shahsafaei A; Wu L; Dorfman DM
Blood; 2000 Jul; 96(2):685-90. PubMed ID: 10887135
[TBL] [Abstract][Full Text] [Related]
24. Detection of mature T-cell leukemias by flow cytometry using anti-T-cell receptor V beta antibodies.
Beck RC; Stahl S; O'Keefe CL; Maciejewski JP; Theil KS; Hsi ED
Am J Clin Pathol; 2003 Nov; 120(5):785-94. PubMed ID: 14608907
[TBL] [Abstract][Full Text] [Related]
25. Chemokine receptor expression and function in childhood acute lymphoblastic leukemia of B-lineage.
Corcione A; Arduino N; Ferretti E; Pistorio A; Spinelli M; Ottonello L; Dallegri F; Basso G; Pistoia V
Leuk Res; 2006 Apr; 30(4):365-72. PubMed ID: 16118018
[TBL] [Abstract][Full Text] [Related]
26. CD26: a novel treatment target for T-cell lymphoid malignancies? (Review).
Sato K; Dang NH
Int J Oncol; 2003 Mar; 22(3):481-97. PubMed ID: 12579300
[TBL] [Abstract][Full Text] [Related]
27. Expression of CCR4 in adult T-cell leukemia.
Yoshie O
Leuk Lymphoma; 2005 Feb; 46(2):185-90. PubMed ID: 15621800
[TBL] [Abstract][Full Text] [Related]
28. Chemokine receptor expression in B-cell lymphoproliferative disorders.
Wong S; Fulcher D
Leuk Lymphoma; 2004 Dec; 45(12):2491-6. PubMed ID: 15621766
[TBL] [Abstract][Full Text] [Related]
29. CXCL13 is highly produced by Sézary cells and enhances their migratory ability via a synergistic mechanism involving CCL19 and CCL21 chemokines.
Picchio MC; Scala E; Pomponi D; Caprini E; Frontani M; Angelucci I; Mangoni A; Lazzeri C; Perez M; Remotti D; Bonoldi E; Benucci R; Baliva G; Lombardo GA; Napolitano M; Russo G; Narducci MG
Cancer Res; 2008 Sep; 68(17):7137-46. PubMed ID: 18757429
[TBL] [Abstract][Full Text] [Related]
30. The vacuolated glycogen-laden leukemic lymphocytes of a T-cell lymphoproliferative disorder.
Krauss JS; Pantazis CG; Spurlock BO; Price LM; Neeley AE
Arch Pathol Lab Med; 1989 Aug; 113(8):937-40. PubMed ID: 2787977
[TBL] [Abstract][Full Text] [Related]
31. Large granular lymphocyte leukemia.
Sokol L; Loughran TP
Oncologist; 2006 Mar; 11(3):263-73. PubMed ID: 16549811
[TBL] [Abstract][Full Text] [Related]
32. Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma.
Brunn A; Montesinos-Rongen M; Strack A; Reifenberger G; Mawrin C; Schaller C; Deckert M
Acta Neuropathol; 2007 Sep; 114(3):271-6. PubMed ID: 17641901
[TBL] [Abstract][Full Text] [Related]
33. The biological environment of Hodgkin's lymphoma and the role of the chemokine CCL17/TARC.
Hnátková M; Mociková H; Trnený M; Zivný J
Prague Med Rep; 2009; 110(1):35-41. PubMed ID: 19591376
[TBL] [Abstract][Full Text] [Related]
34. Thymic microenvironments for T-cell repertoire formation.
Nitta T; Murata S; Ueno T; Tanaka K; Takahama Y
Adv Immunol; 2008; 99():59-94. PubMed ID: 19117532
[TBL] [Abstract][Full Text] [Related]
35. Chemokine receptors are infrequently expressed in malignant and benign mesothelial cells.
Davidson B; Dong HP; Holth A; Berner A; Risberg B
Am J Clin Pathol; 2007 May; 127(5):752-9. PubMed ID: 17439834
[TBL] [Abstract][Full Text] [Related]
36. [Unclassified mature T cell leukemia with cerebriform nuclei].
Takizawa M; Matsushima T; Yokohama A; Handa H; Tsukamoto N; Karasawa M; Murakami H; Nojima Y
Rinsho Ketsueki; 2005 Jul; 46(7):486-91. PubMed ID: 16440739
[TBL] [Abstract][Full Text] [Related]
37. [Classification of malignant lymphoma. WHO international proposal].
Diebold J
Ann Pathol; 1998 Oct; 18(4):361-7. PubMed ID: 9827226
[No Abstract] [Full Text] [Related]
38. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
[TBL] [Abstract][Full Text] [Related]
39. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients.
Takahashi N; Matsumoto K; Saito H; Nanki T; Miyasaka N; Kobata T; Azuma M; Lee SK; Mizutani S; Morio T
J Immunol; 2009 May; 182(9):5515-27. PubMed ID: 19380800
[TBL] [Abstract][Full Text] [Related]
40. The chemokine receptor CCR4 is expressed and associated with a poor prognosis in patients with gastric cancer.
Lee JH; Cho YS; Lee JY; Kook MC; Park JW; Nam BH; Bae JM
Ann Surg; 2009 Jun; 249(6):933-41. PubMed ID: 19474687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
